Showing results (621-630 of 905) with videos related to
Sort By:
Pageof 91
Contemporary Clinical Trials|November 2, 2020
Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European countryGeert Molenberghs, Marc Buyse, Steven Abrams, et al.Infection|January 24, 2024
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational studyJoachim Doua, Jesús Rodríguez-Baño, Rachel Froget, et al.Cell Transplantation|November 25, 2010
Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice?Kristien P Reekmans, Jelle Praet, Nathalie De Vocht, et al.Plos One|February 23, 2024
One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019Sien De Koster, Basil Britto Xavier, Christine Lammens, et al.Trials|September 21, 2014
Oral corticosteroid use for clinical and cost-effective symptom relief of sore throat: study protocol for a randomized controlled trialJohanna Cook, Gail Hayward, Matthew Thompson, et al.Journal of Aging and Physical Activity|December 21, 2020
A Qualitative Exploration of Perceptions of a Digital Intervention to Promote Physical Activity in Older AdultsSebastien Pollet, James Denison-Day, Katherine Bradbury, et al.Plos Medicine|July 24, 2020
Probability of sepsis after infection consultations in primary care in the United Kingdom in 2002-2017: Population-based cohort study and decision analytic modelMartin C Gulliford, Judith Charlton, Joanne R Winter, et al.Lancet (London, England)|December 17, 2019
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trialChristopher C Butler, Alike W van der Velden, Emily Bongard, et al.Pilot and Feasibility Studies|December 19, 2022
Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trialXiao-Yang Hu, Tom Oliver, Merlin Willcox, et al.BMJ Open|June 30, 2022
Using nasal sprays to prevent respiratory tract infections: a qualitative study of online consumer reviews and primary care patient interviewsSian Williamson, Laura Dennison, Kate Greenwell, et al.Pageof 91